164 related articles for article (PubMed ID: 18787279)
1. Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India.
Khadgawat R; Makharia GK; Puri K
Indian J Gastroenterol; 2008; 27(3):103-6. PubMed ID: 18787279
[TBL] [Abstract][Full Text] [Related]
2. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
3. Bone density and bone metabolism in patients with inflammatory bowel disease.
Shirazi KM; Somi MH; Rezaeifar P; Fattahi I; Khoshbaten M; Ahmadzadeh M
Saudi J Gastroenterol; 2012; 18(4):241-7. PubMed ID: 22824766
[TBL] [Abstract][Full Text] [Related]
4. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
5. [Bone mineral density in inflammatory bowel diseases in children].
Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and inflammatory bowel disease severity.
Lima CA; Lyra AC; Mendes CMC; Lopes MB; Coqueiro FG; Rocha R; Santana GO
Braz J Med Biol Res; 2017 Oct; 50(12):e6374. PubMed ID: 29069227
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E
Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area.
Ahmed SF; Horrocks IA; Patterson T; Zaidi S; Ling SC; McGrogan P; Weaver LT
J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):276-80. PubMed ID: 15076625
[TBL] [Abstract][Full Text] [Related]
9. Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
Casals-Seoane F; Chaparro M; Maté J; Gisbert JP
Inflamm Bowel Dis; 2016 Aug; 22(8):1929-36. PubMed ID: 27135482
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for low bone mineral density in ulcerative colitis.
Bundela RPS; Ashdhir P; Narayan KS; Jain M; Pokharna RK; Nijhawan S
Indian J Gastroenterol; 2017 May; 36(3):193-196. PubMed ID: 28643272
[TBL] [Abstract][Full Text] [Related]
11. Bone density improves with disease remission in patients with inflammatory bowel disease.
Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
[TBL] [Abstract][Full Text] [Related]
12. Dietary calcium intake in patients with inflammatory bowel disease.
Vernia P; Loizos P; Di Giuseppantonio I; Amore B; Chiappini A; Cannizzaro S
J Crohns Colitis; 2014 Apr; 8(4):312-7. PubMed ID: 24090907
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis and determinants of bone density in patients with Crohn's disease.
Robinson RJ; al-Azzawi F; Iqbal SJ; Kryswcki T; Almond L; Abrams K; Mayberry JF
Dig Dis Sci; 1998 Nov; 43(11):2500-6. PubMed ID: 9824142
[TBL] [Abstract][Full Text] [Related]
14. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.
Kaya G; Koçak E; Akbal E; Taş A; Köklü S
South Med J; 2011 Nov; 104(11):747-51. PubMed ID: 22024784
[TBL] [Abstract][Full Text] [Related]
16. Discriminatory ability of calcaneal quantitative ultrasound in the assessment of bone status in patients with inflammatory bowel disease.
Turk N; Kastelan D; Cukovic-Cavka S; Kraljevic I; Korsic M; Vucelic B
Ultrasound Med Biol; 2007 Jun; 33(6):863-9. PubMed ID: 17434664
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseases.
Krela-Kaźmierczak I; Szymczak-Tomczak A; Łykowska-Szuber L; Wysocka E; Michalak M; Stawczyk-Eder K; Waszak K; Linke K; Eder P
Adv Clin Exp Med; 2018 Apr; 27(4):449-453. PubMed ID: 29558031
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of osteoporosis and osteopenia in a population of patients with inflammatory bowel diseases from the Wielkopolska Region.
Krela-Kaźmierczak I; Michalak M; Szymczak-Tomczak A; Łykowska-Szuber L; Stawczyk-Eder K; Waszak K; Kucharski MA; Dobrowolska A; Eder P
Pol Arch Intern Med; 2018 Aug; 128(7-8):447-454. PubMed ID: 30057387
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
[TBL] [Abstract][Full Text] [Related]
20. Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort.
Schoon EJ; van Nunen AB; Wouters RS; Stockbrügger RW; Russel MG
Scand J Gastroenterol Suppl; 2000; (232):43-7. PubMed ID: 11232491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]